# FDA 483 - Airgas USA LLC - April 23, 2026

Source: https://www.keypedia.com/records/483/airgas-usa-llc/6e1e6d26-50f2-4f4f-9f15-f7595481c040

> FDA 483 for Airgas USA LLC on April 23, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Airgas USA LLC
- Inspection Date: 2026-04-23
- Product Type: drugs
- Office Name: Seattle District Office
- Summary: Airgas USA, LLC, a medical gas manufacturer in Kent, WA, was cited for significant quality control deficiencies during an FDA inspection. Observations included a lack of written procedures for managing non-operational equipment, critical documentation errors by a bulk driver, and inadequate investigations into internal non-conformances. Additionally, the firm failed to maintain proper calibration and accountability for its Distributed Control System due to the use of shared login credentials.

## Related Officers

- [Gloria E. Andia](https://www.keypedia.com/people/gloria-e-andia/50f145fd-5e25-4a02-bc59-364bcb02b9c8)
- [FDA_PERSONNEL](https://www.keypedia.com/people/aranjeet-singh/7359f43e-0e36-4cdd-a77d-3371d8b44b99)

Company: https://www.keypedia.com/companies/airgas-usa-llc/bc6cc86a-c22c-4e0f-a96d-46a4a32da166

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913